Anbio Biotechnology (NNNN)
NASDAQ: NNNN · Real-Time Price · USD
7.55
+0.14 (1.89%)
At close: Mar 28, 2025, 4:00 PM
7.51
-0.04 (-0.52%)
Pre-market: Mar 31, 2025, 4:03 AM EDT

Anbio Biotechnology Revenue

Anbio Biotechnology had revenue of $5.85M in the half year ending June 30, 2024, a decrease of -67.21%. This brings the company's revenue in the last twelve months to $9.50M, up 8.43% year-over-year. In the year 2023, Anbio Biotechnology had annual revenue of $6.71M, down -71.49%.

Revenue (ttm)
$9.50M
Revenue Growth
+8.43%
P/S Ratio
33.60
Revenue / Employee
$351,928
Employees
27
Market Cap
331.38M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20236.71M-16.83M-71.49%
Dec 31, 202223.54M19.12M431.67%
Dec 31, 20214.43M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition